全文获取类型
收费全文 | 7254篇 |
免费 | 893篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 114篇 |
儿科学 | 124篇 |
妇产科学 | 93篇 |
基础医学 | 332篇 |
口腔科学 | 127篇 |
临床医学 | 795篇 |
内科学 | 1151篇 |
皮肤病学 | 59篇 |
神经病学 | 400篇 |
特种医学 | 146篇 |
外国民族医学 | 1篇 |
外科学 | 784篇 |
综合类 | 513篇 |
预防医学 | 2182篇 |
眼科学 | 58篇 |
药学 | 863篇 |
2篇 | |
中国医学 | 71篇 |
肿瘤学 | 407篇 |
出版年
2024年 | 5篇 |
2023年 | 130篇 |
2022年 | 174篇 |
2021年 | 306篇 |
2020年 | 356篇 |
2019年 | 431篇 |
2018年 | 409篇 |
2017年 | 391篇 |
2016年 | 290篇 |
2015年 | 295篇 |
2014年 | 473篇 |
2013年 | 684篇 |
2012年 | 414篇 |
2011年 | 468篇 |
2010年 | 359篇 |
2009年 | 326篇 |
2008年 | 326篇 |
2007年 | 360篇 |
2006年 | 291篇 |
2005年 | 252篇 |
2004年 | 249篇 |
2003年 | 200篇 |
2002年 | 187篇 |
2001年 | 159篇 |
2000年 | 109篇 |
1999年 | 91篇 |
1998年 | 81篇 |
1997年 | 57篇 |
1996年 | 65篇 |
1995年 | 42篇 |
1994年 | 24篇 |
1993年 | 37篇 |
1992年 | 20篇 |
1991年 | 30篇 |
1990年 | 21篇 |
1989年 | 16篇 |
1988年 | 14篇 |
1987年 | 11篇 |
1986年 | 5篇 |
1985年 | 9篇 |
1984年 | 16篇 |
1983年 | 3篇 |
1982年 | 8篇 |
1981年 | 4篇 |
1980年 | 8篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 4篇 |
1976年 | 2篇 |
1975年 | 2篇 |
排序方式: 共有8222条查询结果,搜索用时 125 毫秒
121.
122.
Objective. To quantify the impact of pharmacy students’ clinical interventions in terms of number and cost savings throughout advanced pharmacy practice experiences (APPEs) using a Web-based documentation program.Methods. Five hundred eighty doctor of pharmacy (PharmD) students completing ten 4-week APPEs during the final year of the curriculum were asked to document all clinical interventions they made using a Web-based documentation tool. Data were collected over 4 academic years.Results. The total number of interventions made was 59,613, the total dollars saved was $8,583,681, and the average savings per intervention was $148. The top 3 categories of interventions made by students were identifying dosing issues, conducting chart reviews, and recommending appropriate therapy. The top 3 intervention types made by students that resulted in the most dollars saved per intervention were identifying potential allergic reactions, identifying drug interactions, and resolving contraindications.Conclusions. Pharmacy students made important and cost-effective clinical interventions during their APPEs that resulted in significant savings. Documentation programs can track the number, type, and value of the interventions that pharmacy students are making. 相似文献
123.
《Gait & posture》2014,39(1):187-192
Estimates of gait characteristics may suffer from errors due to discrepancies in accelerometer location. This is particularly problematic for gait measurements in daily life settings, where consistent sensor positioning is difficult to achieve. To address this problem, we equipped 21 healthy adults with tri-axial accelerometers (DynaPort MiniMod, McRoberts) at the mid and lower lumbar spine and anterior superior iliac spine (L2, L5 and ASIS) while continuously walking outdoors back and forth (20 times) over a distance of 20 m, including turns. We compared 35 gait characteristics between sensor locations by absolute agreement intra-class correlations (2, 1; ICC). We repeated these analyses after applying a new method for off-line sensor realignment providing a unique definition of the vertical and, by symmetry optimization, the two horizontal axes. Agreement between L2 and L5 after realignment was excellent (ICC > 0.9) for stride time and frequency, speed and their corresponding variability and good (ICC > 0.7) for stride regularity, movement intensity, gait symmetry and smoothness and for local dynamic stability. ICC values benefited from sensor realignment. Agreement between ASIS and the lumbar locations was less strong, in particular for gait characteristics like symmetry, smoothness, and local dynamic stability (ICC generally < 0.7). Unfortunately, this lumbar-ASIS agreement did not benefit consistently from sensor realignment. Our findings show that gait characteristics are robust against limited repositioning error of sensors at the lumbar spine, in particular if our off-line realignment is applied. However, larger positioning differences (from lumbar positions to ASIS) yield less consistent estimates and should hence be avoided. 相似文献
124.
125.
Yeongchull Choi Younhee Kim Yousun Ko Eun S. Cha Jaeyoung Kim Won J. Lee 《Tropical medicine & international health : TM & IH》2012,17(12):1534-1543
Objectives To investigate the magnitude and characteristics of the economic burden resulting from acute pesticide poisoning (APP) in South Korea. Methods The total costs of APP from a societal perspective were estimated by summing the direct medical and non‐medical costs together with the indirect costs. Direct medical costs for patients assigned a disease code of pesticide poisoning were extracted from the Korean National Health Insurance Reimbursement Data. Direct non‐medical costs were estimated using the average transportation and caregiving costs from the Korea Health Panel Survey. Indirect costs, incurred by pre‐mature deaths and work loss, were obtained using 2009 Life Tables for Korea and other relevant literature. Results In 2009, a total of 11 453 patients were treated for APP and 1311 died, corresponding to an incidence of 23.1 per 100 000 population and a mortality rate of 2.6 per 100 000 population in South Korea. The total costs of APP were estimated at approximately US$ 150 million, 0.3% of the costs of total diseases. Costs due to pre‐mature mortality accounted for 90.6% of the total costs, whereas the contribution of direct medical costs was relatively small. Conclusion Costs from APP demonstrate a unique characteristic of a large proportion of the indirect costs originating from pre‐mature mortality. This finding suggests policy implications for restrictions on lethal pesticides and safe storage to reduce fatality and cost due to APP. 相似文献
126.
Craig W. Lindsley 《ACS medicinal chemistry letters》2014,5(10):1066-1068
Pharmacoeconomics
is a rational, scientific approach to compare
the value (in terms of both cost and patient outcome) of one medication
or drug therapy regimen to another. The impact of this new approach
on both the practicing medicinal chemist and broader drug discovery
efforts is considered. 相似文献
127.
Colin T Dollery 《British journal of pharmacology》2014,171(9):2269-2290
Translational medicine is a roller coaster with occasional brilliant successes and a large majority of failures. Lost in Translation 1 (‘LiT1’), beginning in the 1950s, was a golden era built upon earlier advances in experimental physiology, biochemistry and pharmacology, with a dash of serendipity, that led to the discovery of many new drugs for serious illnesses. LiT2 saw the large-scale industrialization of drug discovery using high-throughput screens and assays based on affinity for the target molecule. The links between drug development and university sciences and medicine weakened, but there were still some brilliant successes. In LiT3, the coverage of translational medicine expanded from molecular biology to drug budgets, with much greater emphasis on safety and official regulation. Compared with R&D expenditure, the number of breakthrough discoveries in LiT3 was disappointing, but monoclonal antibodies for immunity and inflammation brought in a new golden era and kinase inhibitors such as imatinib were breakthroughs in cancer. The pharmaceutical industry is trying to revive the LiT1 approach by using phenotypic assays and closer links with academia. LiT4 faces a data explosion generated by the genome project, GWAS, ENCODE and the ‘omics’ that is in danger of leaving LiT4 in a computerized cloud. Industrial laboratories are filled with masses of automated machinery while the scientists sit in a separate room viewing the results on their computers. Big Data will need Big Thinking in LiT4 but with so many unmet medical needs and so many new opportunities being revealed there are high hopes that the roller coaster will ride high again. 相似文献
128.
129.
Jonny K. Andersson Elisabeth Hansson-Olofsson Jón Karlsson Jan Fridén 《Journal of plastic surgery and hand surgery》2018,52(1):30-36
Objective: The total number and cost of wrist MRIs in the catchment area of the Västra Götaland Region in Sweden (population 1 723 000) during 1 year was analysed, together with the number and content of referrals.Methods: Six radiology departments reported the numbers and rate of all MRI investigations intended to diagnose wrist ligament injuries (n?=?411) and other injuries to the wrist.Results: The additional cost of the difference between MRIs and a clinical examination by a hand surgeon, plus indirect costs for patients with suspected wrist ligament injuries, was calculated as 957 000 euros.Conclusions: It is recommended that MRI should only be used in patients in whom there are clinical difficulties in terms of diagnosing wrist ligament injuries. It is suggested that patients with suspected wrist ligament injuries should be referred directly to an experienced hand surgeon, capable of performing a standardised wrist examination and, when needed, diagnostic arthroscopy and final treatment. The proposed algorithm for the diagnosis and treatment of suspected wrist ligament injuries presented in the present study could save time for the patient and for the radiology departments, as well as reducing costs. The ability to implement the early and appropriate treatment of acute ligament injuries could be improved at the same time. 相似文献
130.
Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective 下载免费PDF全文